UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 590.

A

Abbott, WGH; Rigópoulou, E; Haigh, P; Cooksley, H; Mullerova, I; Novelli, M; Winstanley, A; (2004) Single nucleotide polymorphisms in the interferon-γ and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus. Liver International , 24 (2) pp. 90-97.

Abdalla, S; Lao-Sirieix, P; Novelli, M; Lovat, LB; Fitzgerald, RC; (2004) Relationship of COX-2 expression to gastrin and cell differentiation status in Barrett's esophagus and associated carcinoma. Clinical Cancer Research , 10 pp. 4784-4792.

Abdalla, S; Sanderson, ; (2004) Variable cyclooxygenase (COX)-2 expression in Barrett's associated adenocarcinoma. Relationship to tumour differentiation. In: (pp. 223-).

Abdalla, SI; Lao-Sirieix, P; Novelli, MR; Lovat, LB; Sanderson, IR; Fitzgerald, RC; (2004) Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenes. CLIN CANCER RES , 10 (14) 4784 - 4792.

Adib, TR; Henderson, S; Perrett, C; Hewitt, D; Bourmpoulia, D; Ledermann, J; Boshoff, C; (2004) Predicting biomarkers for ovarian cancer using gene-expression microarrays. British Journal of Cancer , 90 (3) pp. 686-692. 10.1038/sj.bjc.6601603.

Adib, TR; Henderson, S; Perrett, C; Hewitt, D; Bourmpoulia, D; Ledermann, J; Boshoff, C; (2004) Predicting biomarkers for ovarian cancer using gene-expression microarrays. BRIT J CANCER , 90 (3) 686 - 692. 10.1038/sj.bjc.6601603.

Ah-See, MW; Makris, A; Taylor, NJ; Harrison, M; Ostler, PJ; Richman, PI; Stirling, JJ; (2004) Changes in dynamic contrast-enhanced MRI as an early predictor of response to neoadjuvant chemotherapy in primary breast cancer. British Journal of Cancer , 91 S22-S22.

Ah-See, MW; Padhani, AR; Taylor, NJ; Daley, FM; Bentzen, SM; Burcombe, RJ; Harrison, M; (2004) Tumour microvasculature, assessment by dynamic contrast- enhanced MRI fails to correlate with VEGF expression in breast cancer biopsies. British Journal of Cancer , 91 S16-S16.

Ahmed, F; Ings, SJ; Pizzey, AR; Blundell, MP; Thrasher, AJ; T Ye, H; Fahey, A; (2004) Impaired bone marrow homing of cytokine-activated CD34(+) cells in the NOD/SCID model. BLOOD , 103 (6) 2079 - 2087. 10.1182/blood-2003-06-1770.

Ahmed, F; Ings, SJ; Pizzey, AR; Blundell, MP; Thrasher, AJ; Ye, HT; Fahey, A; (2004) Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model. Blood , 103 (6) pp. 2079-2087. 10.1182/blood-2003-06-1770. Green open access
file

Akbar, AN; Beverley, PCL; Salmon, M; (2004) Opinion - Will telomere erosion lead to a loss of T-cell memory? NAT REV IMMUNOL , 4 (9) 737 - 743. 10.1038/nri1440.

Ali, K; Bilancio, A; Thomas, M; Pearce, W; Gilfillan, AM; Tkaczyk, C; Kuehn, N; (2004) Essential role for the p110 delta phosphoinositide 3-kinase in the allergic response. NATURE , 431 (7011) pp. 1007-1011. 10.1038/nature02991.

Ali, K; Bilancio, A; Thomas, M; Pearce, W; Gilfillan, AM; Tkaczyk, C; Kuehn, N; (2004) Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature , 431 (7011) pp. 1007-1011. 10.1038/nature02991.

Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2004) Increased expression of the low affinity IgG receptor FcR gamma IIA (CD32) in platelet RNA from patients with chronic myeloproliferative disorders demonstrated by representational difference analysis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 39 - 39). BLACKWELL PUBLISHING LTD

Alley, MC; Hollingshead, MG; Pacula-Cox, CM; Wand, WR; Hartley, JA; Howard, PW; Gregson, SJ; (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations. CANCER RES , 64 (18) 6700 - 6706.

Amin, S; Chong, NHV; Bailey, TA; Zhang, JJ; Knupp, C; Cheetham, ME; Greenwood, J; (2004) Modulation of Sub-RPE deposits in vitro: A potential model for age-related macular degeneration. INVEST OPHTH VIS SCI , 45 (5) 1281 - 1288. 10.1167/iovs.03-0671.

Anderson, LJ; Westwood, MA; Holden, S; Davis, B; Prescott, E; Wonke, B; Porter, JB; (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. British Journal of Haematology , 127 (3) pp. 348-355.

Anderson, LJ; Westwood, MA; Holden, S; Davis, B; Prescott, E; Wonke, B; Porter, JB; (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance. BRIT J HAEMATOL , 127 (3) 348 - 355. 10.1111/j.1365-2141.2004.05202.x.

André, T; Boni, C; Mounedji-Boudiaf, L; Navarro, M; Tabernero, J; Hickish, T; Topham, C; (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med , 350 (23) pp. 2343-2351. 10.1056/NEJMoa032709. Green open access
file

Ansari, J; Nagabhushan, N; Syed, R; Bomanji, J; Bacon, CM; Lee, SM; (2004) Small cell lung cancer associated with anti-Hu paraneoplastic sensory neuropathy and peripheral nerve microvasculitis: Case report and literature review. CLINICAL ONCOLOGY , 16 (1) pp. 71-76. 10.1016/j.clon.2003.09.008.

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; Remstein, ED; (2004) Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. LEUKEMIA , 18 (3) pp. 616-623. 10.1038/sj.leu.2403281.

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; Remstein, ED; (2004) Inihibitor of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia , 18 (3) pp. 616-623. 10.1038/sj.leu.2403281.

Arkenau, HT; Porschen, R; (2004) Adjuvant chemotherapy in curative resected colon carcinoma. Verdauungskrankheiten , 22 (4) pp. 208-215.

Arkenau, HT; Porschen, R; (2004) Adjuvante Therapie des kolorektalen Karzinoms. Verdauungskrankheiten pp. 208-215.

Attygalle, AD; Diss, TC; Munson, P; Isaacson, PG; Du, MQ; Dogan, A; (2004) CD10 expression in extranodal dissemination of Angioimmunoblastic T-cell lymphoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY , 28 (1) pp. 54-61. 10.1097/00000478-200401000-00005.

Attygalle, AD; Liu, HX; Shirali, S; Diss, TC; Loddenkemper, C; Stein, H; Dogan, A; (2004) Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. BLOOD , 104 (10) pp. 3343-3348. 10.1182/blood-2004-01-0385. Green open access
file

Avivi, I; Chakrabarti, S; Kottaridis, P; Kyriaku, C; Dogan, A; Milligan, D; Linch, D; (2004) Neurological complications following alemtuzumab-based reduced- intensity allogeneic transplantation. BONE MARROW TRANSPLANTATION , 34 (2) pp. 137-142.

Avivi, I; Chakrabarti, S; Kottaridis, P; Kyriaku, C; Dogan, A; Milligan, DW; Linch, D; (2004) Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. Bone Marrow Transplant , 34 (2) pp. 137-142. 10.1038/sj.bmt.1704538.

Avivi, I; Chakrabarti, S; Milligan, DW; Waldmann, H; Hale, G; Osman, H; Ward, KN; (2004) Incidence and outcome of Adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. BIOL BLOOD MARROW TR , 10 (3) 186 - 194. 10.1016/j.bbmt.2003.11.001.

Avivi, I; Chakrabarti, S; Milligan, DW; Waldmann, H; Hale, G; Osman, H; Ward, KN; (2004) Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol Blood Marrow Transplant , 10 (3) pp. 186-194. 10.1016/j.bbmt.2003.11.001.

B

BBC, NO; (2004) Drug boosts lung cancer survival. UNSPECIFIED

BBC, NORCR; (2004) 'They just didn't know what it would do'. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Passive smoking is a public health hazard. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Smart drug for lung cancer tested. UNSPECIFIED

Bacon, C; Miller, R; Noursadeghi, M; McNamara, C; Du, M; Dogan, A; (2004) Pathology of bone marrow in human herpes virus-8 HHV8-associated multicentric Castleman disease. BRITISH JOURNAL OF HAEMATOLOGY , 127 (5) pp. 585-591.

Bacon, CM; Miller, RF; Noursadeghi, M; McNamara, C; Du, MQ; Dogan, A; (2004) Pathology of bone marrow in human herpes virus-8 (HHV8)-associated multicentric Castleman disease. BRIT J HAEMATOL , 127 (5) 585 - 591. 10.1111/j.1365-2141.2004.05230.x.

Bagshawe, KD; Sharma, SK; Begent, RHJ; (2004) Antibody-directed enzyme prodrug therapy (ADEPT) for cancer. EXPERT OPIN BIOL TH , 4 (11) 1777 - 1789. 10.1517/14712598.4.11.1777.

Balsa, C; Watts, MJ; Ings, SJ; Linch, DC; (2004) Unexpected differences in the thaw clonogenic recovery of pre-stressed peripheral blood stem cells according to the cryoprotectant used. In: BONE MARROW TRANSPLANTATION. (pp. S93 - S93). NATURE PUBLISHING GROUP

Baraldi, PG; Beria, I; Cozzi, P; Geroni, C; Espinosa, A; Gallo, MA; Entrena, A; (2004) Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies. BIOORGAN MED CHEM , 12 (14) 3911 - 3921. 10.1016/j.bmc.2004.04.045.

Barber, L; Whitelegg, A; Madrigal, J; Banner, N; Rose, M; (2004) Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. TRANSPLANTATION , 77 (10) pp. 1604-1609.

Barber, L; Whitelegg, A; on, M; igal, J; Banner, N; olas, R; (2004) Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. TRANSPLANTATION , 77 (10) pp. 1604-1609.

Bates, AW; (2004) The sooterkin doctor: the London career of John Maubray, MD (1700-1732), "andro-boethogynist". J Med Biogr , 12 (3) pp. 147-153. 10.1177/096777200401200309.

Beck, M; Cox, TM; Mehta, AB; Widmer, U; (2004) Lysosomal diseases: natural course, pathology and therapy. [Book]. (Vol.94, Su). Taylor & Francis

Beck, M; Ricci, R; Widmer, U; Dehout, F; Garciade, L; Kampmann, C; Linhart, A; (2004) Fabry disease: overall effects of agalsidase alfa treatment. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 Dec (12) pp. 838-44.

Beck, S; (2004) Dr Nat Bumstead: Pioneer researcher in mapping the chicken genome. DNA SEQUENCE , 15 (3) 165 - 166. 10.1080/10425170410001716073.

Beck, S; (2004) Haplotypes revisited: Genetic and epigenetic variation of the MHC. In: TISSUE ANTIGENS. (pp. 327 - 328). BLACKWELL MUNKSGAARD

Bell, CG; Benzinou, M; Siddiq, A; Lecoeur, C; Dina, C; Lemainque, A; Clément, K; (2004) Genome-wide linkage analysis for severe obesity in french caucasians finds significant susceptibility locus on chromosome 19q. Diabetes , 53 (7) pp. 1857-1865.

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Melino, G; Cossarizza, A; Heery, D; (2004) Mutant PML proteins form novel cytoplasmic bodies. In: BLOOD. (pp. 952A - 952A). AMER SOC HEMATOLOGY

Benchaouir, R; Rameau, P; Decraene, C; Dreyfus, P; Israeli, D; Piétu, G; Danos, O; (2004) Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line: a tool to explore muscle stem cell biology. Exp Cell Res , 294 (1) pp. 254-268. 10.1016/j.yexcr.2003.11.005.

Bentzen, SM; Bernier, J; Khalil, AA; Saunders, MI; Horiot, JC; Van den Bogaert, W; Cummings, BJ; (2004) Estimatet effect of patient non-compliance to dose-time constraints in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Strahlentherapie und Onkologie , 180 p. 98.

Bernassola, F; Salomoni, P; Oberst, A; Di Como, CJ; Pagano, M; Melino, G; Pandolfi, PP; (2004) Ubiquitin-dependent degradation of p73 is inhibited by PML. J EXP MED , 199 (11) 1545 - 1557. 10.1084/jem.20031943.

Bhattacharjya, S; Bhattacharjya, T; Quaglia, A; Dhillon, AP; Burroughs, AK; Patch, DW; Tibballs, JM; (2004) Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: An analysis of pre-operative imaging, explant histology and prognostic histologic indicators. DIGEST SURG , 21 (2) 152 - 159. 10.1159/000078741.

Birnie, A; Gazzard, BG; Bacon, C; Dogan, A; Shaw, PJ; Miller, RF; (2004) Fever in the recently returned HIV infected traveller. SEX TRANSM INFECT , 80 (2) 86 - 90. 10.1136/sti.2003.008755.

Birtle, AJ; Newby, JC; Harland, SJ; (2004) Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer. British Journal of Cancer , 91 (8) pp. 1472-1476.

Bourboulia, D; Aldam, D; Lagos, D; Allen, E; Williams, I; Cornforth, D; Copas, A; (2004) Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS , 18 (3) pp. 485-493. 10.1097/00002030-200402200-00015.

Bourboulia, D; Aldam, D; Lagos, D; Allen, E; Williams, I; Cornforth, D; Copas, A; (2004) Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS , 18 (3) 485 - 493. 10.1097/01.aids.0000111409.02002.b8.

Bourboulia, D.; (2004) Humoral and cellular immune responses against Kaposi's sarcoma-associated herpesvirus (KSHV). Doctoral thesis, University of London. Green open access
file

Bouscary, D; Bardet, V; Sujobert, P; Cornillet-Lefebvre, P; Hayflick, JS; Prie, N; Verdier, F; (2004) Blockade of p110delta isoform activity of phosphoinositide 3-kinase inhibits blast cell proliferation in acute myeloblastic leukemia. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 691A-691A). AMER SOC HEMATOLOGY

Boven, L; van, M; Boot, R; Mehta, A; Boon, L; Aerts, J; Laman, J; (2004) Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. AMERICAN JOURNAL OF CLINICAL PATHOLOGY , 122 (3) pp. 359-369.

Bowen, D; Hyslop, A; Keenan, N; Groves, M; Culligan, D; Johnson, P; Shaw, A; (2004) Prediction of response to recombinant erythropoietin plus granulocyte-colony stimulating factor following a single subcutaneous bolus in patients with myelodysplastic syndromes; a randomised placebo controlled study. In: BLOOD. (pp. 402A - 402A). AMER SOC HEMATOLOGY

Bower, M; Powles, T; Newsom-Davis, T; Thirlwell, C; Stebbing, J; Mandalia, S; Nelson, M; (2004) HIV-associated anal cancer - Has highly active antiretroviral therapy reduced the incidence or improved the outcome? JAIDS-J ACQ IMM DEF , 37 (5) 1563 - 1565.

Bower, M; Stebbing, J; Thirlwell, C; Newsom-Davis, T; Waterston, A; Mandalia, S; Gazzard, B; (2004) Anti-retroviral treatment regimens and immune parameters in the prevention of systemic HIV-related non-Hodgkin's lymphoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 105S - 105S). AMER SOC CLINICAL ONCOLOGY

Bower, M; Stebbing, J; Thirlwell, C; Newsom-Davis, T; Waterston, A; Mandalia, S; Gazzard, B; (2004) Anti-retroviral treatment regimens and immune parameters in the prevention of systemic HIV-related non-Hodgkin's lymphoma. J Clin Oncol , 22 (14_suppl) 1034-.

Bownes, P; Hoskin, PJ; Ostler, PJ; Lowe, GJ; Bryant, L; (2004) Quality assurance for fractionated high dose rate afterloading brachytherapy as monotherapy for prostate cancer. Radiotherapy and Oncology , 71 241-.

Boxall, EH; Sira, J; Standish, RA; Davies, P; Sleight, E; Dhillon, AP; Scheuer, PJ; (2004) Natural history of hepatitis B in perinatally infected carriers. ARCH DIS CHILD , 89 (5) F456 - F460. 10.1136/adc.2002.009837.

Brealey, D; Karyampudi, S; Jacques, TS; Novelli, M; Stidwill, R; Taylor, V; Smolenski, RT; (2004) Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. AM J PHYSIOL-REG I , 286 (3) R491 - R497. 10.1152/ajpregu.00432.2003.

Brooks, SP; Ebenezer, N; Poopalasundaram, S; Maher, E; Francis, P; Moore, A; Hardcastle, A; (2004) Refinement of the X-linked cataract locus (CXN) and gene analysis for CXN and Nance-Horan syndrome (NHS). Ophthalmic Genet , 25 (2) pp. 121-131.

Brooks, SP; Ebenezer, ND; Poopalasundaram, S; Lehmann, OJ; Moore, AT; Hardcastle, AJ; (2004) Identification of the gene for Nance-Horan syndrome (NHS). J MED GENET , 41 (10) 768 - 771. 10.1136/jmg.2004.022517.

Bruno, L; Hoffman, R; McBlane, F; Brown, J; Gupta, R; Joshi, C; Pearson, S; (2004) Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Molecular and Cellular Biology , 24 (2) pp. 741-756. 10.1128/MCB.24.2.741-756.2004.

Bruno, L; Hoffmann, R; McBlane, F; Brown, J; Gupta, R; Joshi, C; Pearson, S; (2004) Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. MOLECULAR AND CELLULAR BIOLOGY , 24 (2) pp. 741-756. 10.1128/MCB.24.2.741-756.2004.

Burk, K; (2004) Colonial America, the Founding Fathers and Wine. The World of Fine Wine , None (3) pp. 70-74.

Burk, K; (2004) In Greece, Drink Greek Wine. Prospect (8/04) p. 41.

Burk, K; (2004) Wine For Christmas. Prospect (1/2004) p. 45.

Burns, S; Hardy, SJ; Buddle, J; Yong, KL; Jones, GE; Thrasher, AJ; (2004) Maturation of DC is associated with changes in motile characteristics and adherence. CELL MOTIL CYTOSKEL , 57 (2) 118 - 132. 10.1002/cm.10163.

Burroughs, A; Hochhauser, D; Meyer, T; (2004) Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. LANCET ONCOL , 5 (7) 409 - 418.

Burroughs, A; Hochhauser, D; Meyer, T; (2004) Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. Lancet Oncol , 5 (7) pp. 409-418. 10.1016/S1470-2045(04)01508-6.

Burton, C; Ell, P; Linch, D; (2004) The role of PET imaging in lymphoma. BRITISH JOURNAL OF HAEMATOLOGY , 126 (6) pp. 772-784. 10.1111/j.1365-2141.2004.05069.x.

Butcher, LM; Meaburn, E; Liu, L; Fernandes, C; Hill, L; Al-Chalabi, A; Plomin, R; (2004) Genotyping pooled DNA on microarrays: a systematic genome screen of thousands of SNPs in large samples to detect QTLs for complex traits. Behav.Genet. , 34 (5) pp. 549-555. 10.1023/B:BEGE.0000038493.26202.d3.

Buyck, HC; Paston, SJ; Lowdell, MW; MacKinnon, S; Emery, VC; (2004) Functional helper T cell response to CMV predicts probability of CMV vireamia following allogeneic stem cell transplantation. In: BLOOD. (pp. 611A - 611A). AMER SOC HEMATOLOGY

C

Calabrese, CR; Almassy, R; Barton, S; Batey, MA; Calvert, AH; Canan-Koch, S; Durkacz, BW; (2004) Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. J NATL CANCER I , 96 (1) 56 - 67. 10.1093/jnci/djh005.

Callies, S; de Alwis, DP; Mehta, A; Burgess, M; Aarons, L; (2004) Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979). Cancer Chemotherapy and Pharmacology , 54 (1) pp. 39-48.

Calvert, AH; (2004) Biochemical pharmacology of pemetrexed. Oncology (Williston Park) , 18 (13 Suppl) pp. 13-17.

Camilleri, RS; Peebles, D; Portmann, C; Everington, T; Cohen, H; (2004) -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. BLOOD COAGUL FIBRIN , 15 (2) 139 - 147. 10.1097/01.mbc.0000114378.15192.1a.

Camilleri, RS; Peebles, D; Portmann, C; Everington, T; Cohen, H; (2004) -455G/A β-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. Blood Coagulation and Fibrinolysis , 15 (2) pp. 139-147. 10.1097/00001721-200403000-00005.

Campbell, M; Allen, WE; Sawyer, C; Vanhaesebroeck, B; Trimble, ER; (2004) Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. Circ Res , 95 (4) pp. 380-388. 10.1161/01.RES.0000138019.82184.5d.

Cansick, JC; Lennon, R; Cummins, CL; Howie, AJ; McGraw, ME; Saleem, MA; Tizard, EJ; (2004) Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative)glomerulonephritis. Nephrology Dialysis Transplantation , 19 pp. 2769-2777.

Carnell, DM; Smith, RE; Daley, FM; Barber, PR; Hoskin, PJ; Wilson, GD; Murray, GI; (2004) Target validation of cytochrome P450CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue. International Journal of Radiation Oncology Biology Physics , 58 (2) pp. 500-509.

Castillon, N; Avril-Delplanque, A; Coraux, C; Delenda, C; Péault, B; Danos, O; Puchelle, E; (2004) Regeneration of a well-differentiated human airway surface epithelium by spheroid and lentivirus vector-transduced airway cells. J Gene Med , 6 (8) pp. 846-856. 10.1002/jgm.570.

Cavenagh, JD; Popat, R; Curry, N; Stec, J; Morris, TC; Drake, M; Agrawal, S; (2004) PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 413A-413A). AMER SOC HEMATOLOGY

Channel, 4IMF; (2004) Happy Birthday Thalidomide. UNSPECIFIED

Chen, JH; Stoeber, K; Kingsbury, S; Ozanne, SE; Williams, GH; Hales, CN; (2004) Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J BIOL CHEM , 279 (47) 49439 - 49446. 10.1074/jbc.M409153200. Gold open access

Chester, JD; Hall, GD; Forster, M; Protheroe, AS; (2004) Systemic chemotherapy for patients with bladder cancer--current controversies and future directions. Cancer Treat Rev , 30 (4) pp. 343-358. 10.1016/j.ctrv.2003.12.005.

Chester, K; Pedley, B; Tolner, B; Violet, J; Mayer, A; Sharma, S; Boxer, G; (2004) Engineering antibodies for clinical applications in cancer. Tumor Biology , 25 (1-2) pp. 91-98.

Chester, K; Pedley, B; Tolner, B; Violet, J; Mayer, A; Sharma, S; Boxer, G; (2004) Engineering antibodies for clinical applications in cancer. TUMOR BIOL , 25 (1-2) 91 - 98. 10.1159/000077727.

Chew, SK; Akdemir, F; Chen, P; Lu, W-J; Mills, K; Daish, T; Kumar, S; (2004) The apical caspase dronc governs programmed and unprogrammed cell death in Drosophila. Dev Cell , 7 (6) pp. 897-907. 10.1016/j.devcel.2004.09.016.

Chicken, D; Johnson, K; Falzon, M; Waddington, W; Ell, P; Bown, S; Keshtgar, M; (2004) Instantaneous detection of sentinel node metastases in breast cancer by "optical biopsy" using elastic scattering spectroscopy. In:

Chicken, D; Johnson, K; Falzon, M; Waddington, W; Ell, P; Bown, S; Keshtgar, M; (2004) Instantaneous detection of sentinel node metastases in breast cancer using elastic scattering spectroscopy. In: (pp. 37-).

Chicken, DW; Johnson, KS; Falzon, MR; Lee, AC; Briggs, G; Pickard, D; Bigio, IJ; (2004) Optical biopsy utilising elastic scattering spectroscopy for intra-operative diagnosis of sentinel lymph node metastases. In: (pp. 841-).

Chow, E; Thirlwell, C; Macrae, F; Lipton, L; (2004) Colorectal cancer and inherited mutations in base-excision repair. LANCET ONCOL , 5 (10) 600 - 606.

Chowdhury, S; Chester, KA; Bridgewater, J; Collins, MK; Martin, F; (2004) Efficient retroviral vector targeting of carcinoembryonic antigen-positive tumors. MOL THER , 9 (1) 85 - 92. 10.1016/j.ymthe.2003.10.004.

Clamp, A; Adams, M; Atkinson, R; Boven, E; Calvert, AH; Cervantes, A; Ganesan, T; (2004) A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-895 1f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer. GYNECOL ONCOL , 95 (1) 114 - 119. 10.1016/j.ygyno.2004.06.047.

Clark, FJ; Gregg, R; Piper, K; Dunnion, D; Freeman, L; Griffiths, M; Begum, G; (2004) Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4(+)CD25(high) regulatory T cells. BLOOD , 103 (6) 2410 - 2416. 10.1182/blood-2003-06-2073.

Clingen, PH; Wu, J; Prise, KM; Hartley, JA; (2004) H2AX nuclear foci are induced in human cells after treatment with DNA interstrand crosslinking chemotherapeutics. BRITISH JOURNAL OF CANCER , 91 S48 - S48.

Coakley, M; Mallet, S; Purdy, G; Self, R; Machin, SJ; Mackie, IJ; (2004) A second cohort of patients with coronary heart disease and reduced VWF cleaving protease activity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING LTD

Cohen, H; (2004) Highlights from the 7th annual report: taking SHOT recommendations forward. [Lecture]. Presented at: SHOT annual symposium, London.

Cohen, H; Jones, H; Stainsby, D; (2004) SHOT 6th annual report - errors remain the predominant finding. In: (Proceedings) British society for haematology annual scientific meeting.

Cohen, H; Nash, M; Cohen, H; Liesner, R; Machin, SJ; (2004) Acquired coagulation disorders. In: Hoffbrand, V and Lewis, M and Tuddenham, E, (eds.) Postgraduate haematology.

Conde, L; Vaquerizas, JM; Santoyo, J; Al-Shahrour, F; Ruiz-Llorente, S; Robledo, M; Dopazo, J; (2004) PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res , 32 (Web Serv) W242-W248. 10.1093/nar/gkh438.

Cooper, N; Avivi, I; Peggs, K; Hart, D; Thomson, K; Goldstone, A; Linch, D; (2004) The role of PET scanning in directing immune manipulations following reduced intensity transplants in adults with lymphoid malignancies. In: BLOOD. (pp. 622A - 623A). AMER SOC HEMATOLOGY

Coyne, JD; Banerjee, SS; Bromley, M; Mills, S; Diss, TC; Harris, M; (2004) Post-translation T-cell lymphoproliferative disorder/T-cell lymphoma: a report of three cases of T-anaplastic large-cell lymphoma with cutaneous presentation and a review of the literature. Histopathology , 44 (4) pp. 387-393.

Craig, CEH; Quaglia, A; Dhillon, AP; (2004) Extramedullary haematopoiesis in massive hepatic necrosis. HISTOPATHOLOGY , 45 (5) 518 - 525.

Craig, CEH; Quaglia, A; Dhillon, AP; (2004) Massive hepatic necrosis and extramedullary haemopoiesis. In: JOURNAL OF HEPATOLOGY. (pp. 42 - 42). ELSEVIER SCIENCE BV

Craig, CEH; Quaglia, A; Selden, C; Lowdell, M; Hodgson, H; Dhillon, AP; (2004) The histopathology of regeneration in massive hepatic necrosis. SEMIN LIVER DIS , 24 (1) 49 - 64.

Curtin, NJ; Barlow, HC; Bowman, KJ; Calvert, AH; Davison, R; Golding, BT; Huang, B; (2004) Resistance-modifying agents. 11. Pyrimido[5,4-d]pyrimidine modulators of antitumor drug activity. Synthesis and structure-activity relationships for nucleoside transport inhibition and binding to alpha(1)-acid glycoprotein. J MED CHEM , 47 (20) 4905 - 4922. 10.1021/jm040772w.

D

D'Sa, S; Yong, K; Kyriakou, C; Bhattacharya, S; Peggs, KS; Foulkes, B; Watts, MJ; (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. British Journal of Haematology , 125 (6) pp. 756-765. 10.1111/j.1365-2141.2004.04981.x.

D'Sa, S; Yong, K; Kyriakou, C; Bhattacharya, S; Peggs, KS; Foulkes, B; Watts, MJ; (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. BRIT J HAEMATOL , 125 (6) 756 - 765. 10.1111/j.1365-2141.2004.04981.x.

Damien, E; Revell, PA; (2004) Changes in distant organs in response to local osteogenic growth factors delivered by intraosseous implants: a histological evaluation. Key Engineering Materials , 254-25 pp. 797-800.

Danovi, D; Meulmeester, E; Pasini, D; Migliorini, D; Capra, M; Frenk, R; de Graaf, P; (2004) Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. MOL CELL BIOL , 24 (13) 5835 - 5843. 10.1128/MCB.24.13.5835-5843.2004.

Davidoff, AM; Nathwani, AC; (2004) Antiangiogenic gene therapy for cancer treatment. Curr Hematol Rep , 3 (4) pp. 267-273.

Davidoff, AM; Ng, CYC; Sleep, S; Gray, J; Azam, S; Zhao, Y; McIntosh, JH; (2004) Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. J VIROL METHODS , 121 (2) 209 - 215. 10.1016/j.jviromet.2004.07.001.

Davies, J; Marden, C; Sviland, L; North, J; Lowdell, MW; (2004) Ex-vivo alloreactive T cell depletion with anti-CD69 - Effects on anti-viral immune-reactivity and donor NK cell function. BLOOD CELLS MOLECULES AND DISEASES , 33 (3) 198 - 198.

Davies, JK; Koh, MBC; Lowdell, MW; (2004) Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings. BIOL BLOOD MARROW TR , 10 (4) 259 - 268. 10.1016/j.bbmt.2003.12.001.

Davis, BA; O'Sullivan, C; Jarritt, PH; Porter, JB; (2004) Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. BLOOD , 104 (1) 263 - 269. 10.1182/blood-2003-08-2841.

De Leval, L; Vivario, M; De Prijck, B; Zhou, Y; Boniver, J; Harris, NL; Isaacson, P; (2004) Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. The American Journal of Surgical Pathology , 28 pp. 679-686.

Dearling, J.L.J.; Flynn, A.A.; Sutcliffe-Goulden, J.; Petrie, I.A.; Boden, R.; Green, A.J.; Boxer, G.M.; (2004) Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. The Journal of Nuclear Medicine , 45 (1) pp. 101-107.

Dearling, JLJ; Flynn, AA; Sutcliffe-Goulden, J; Petrie, IA; Boden, R; Green, AJ; Boxer, GM; (2004) Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J NUCL MED , 45 (1) 101 - 107.

Delaunay, J; Nouyrigat, V; Proust, A; Schischmanoff, P-O; Cynober, T; Yvart, J; Gaillard, C; (2004) Different impacts of alleles alphaLEPRA and alphaLELY as assessed versus a novel, virtually null allele of the SPTA1 gene in trans. Br J Haematol , 127 (1) pp. 118-122. 10.1111/j.1365-2141.2004.05160.x.

Delgado, J; Cooper, N; Thomson, K; Duarte, R; Kottaridis, P; Peggs, K; Mackinnon, S; (2004) The importance of age, fludarabine and total body irradiation in the incidence and severity of chronic renal failure following allogeneic hematopoietic stem cell transplantation. In: BLOOD. (pp. 621A - 621A). AMER SOC HEMATOLOGY

Deloukas, P; Earthrowl, ME; Grafham, DV; Rubenfield, M; French, L; Steward, CA; Sims, SK; (2004) The DNA sequence and comparative analysis of human chromosome 10. NATURE , 429 (6990) 375 - 381. 10.1038/nature02462.

Dhar, A; Johnson, K; Novelli, M; Bown, S; Lovat, L; Bloom, S; (2004) Optical biopsy of colonic lesions: Comparison of elastic scattering spectroscopy with histology. In: GASTROENTEROLOGY. (pp. A76 - A76). W B SAUNDERS CO

Direkze, NC; Hodivala-Dilke, K; Jeffery, R; Hunt, T; Oukrif, D; Preston, SL; Alison, MR; (2004) Bone marrow contributes to tumour stroma. In: JOURNAL OF PATHOLOGY. (pp. 10A - 10A). JOHN WILEY & SONS LTD

Direkze, NC; Hodivala-Dilke, K; Jeffery, R; Hunt, T; Poulsom, R; Oukrif, D; Alison, MR; (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. CANCER RES , 64 (23) 8492 - 8495.

Diss, TC; Baginsky, L; Ye, H; Du, M; Wren, B; Dogan, A; Isaacson, PG; (2004) Campylobacter jejuni is a strong candidate for involvement in the development of immunoproliferative small intestinal disease. In: (Proceedings) 186th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland/Dutch-Pathological-Society. (pp. 8A-8A). JOHN WILEY & SONS LTD

Duarte, RF; Delgado-Gonzalez, J; Quaglia, AF; Shaw, B; Wrench, D; Ethell, M; Dhillon, AP; (2004) Graft-versus-host disease of the liver: 109 cases from a single-centre. BONE MARROW TRANSPLANTATION , 33 S175 - S175.

Duarte, RF; Delgado-Gonzalez, J; Shaw, BE; Wrench, D; Ethell, M; Patch, D; Dhillon, AP; (2004) Pathologic features may predict the clinical outcome of hepatic graft versus host disease (H-GVHD). Blood , 104 (11) 5079-.

Duarte, RF; Delgado-Gonzalez, J; Shaw, BE; Wrench, D; Ethell, M; Patch, D; Dhillon, AP; (2004) Pathologic features may predict the clinical outcome of hepatic graft versus host disease (H-GVHD). In: BLOOD. (pp. 353B - 353B). AMER SOC HEMATOLOGY

Duke, V; Yogashangari, B; Gandini, D; Sherrington, PD; Mehta, A; Hoffbrand, AV; Foroni, L; (2004) Conserved amino acid sequences occur in a limited group of CLL patients with predominantly mutated IGH rearrangements. In: (pp. 552a-552a).

Dumez, H; Van Oosterom, AT; Rothermel, JD; Mull, R; Calvert, AH; (2004) Phase Ib/II dose-escalation trial evaluating the safety and tolerability of EPO906 plus capecitabine in patients with advanced cancer. J Clin Oncol , 22 (14_suppl) 2093-.

Dumez, H; Van Oosterom, AT; Rothermel, JD; Mull, R; Calvert, AH; (2004) Phase Ib/Il dose-escalation trial evaluating the safety and tolerability of EP0906 plus capecitabine in patients with advanced cancer. Journal of Clinical Oncology , 22 (14) 2093-.

Dunham, A; Matthews, LH; Burton, J; Ashurst, JL; Howe, KL; Ashcroft, KJ; Beare, DM; (2004) The DNA sequence and analysis of human chromosome 13. NATURE , 428 (6982) 522 - 528. 10.1038/nature02379.

Dunham, A; Matthews, LH; Burton, J; Ashurst, JL; Howe, KL; Ashcroft, KJ; Beare, DM; (2004) The DNA sequence and analysis of human chromosome 13. Nature , 425 (6960) pp. 805-811. 10.1038/nature02379.

Dunham, A.; Matthews, L.H.; Burton, J.; Ashurst, J.L.; Howe, K.L.; Ashcroft, K.J.; Beare, D.M.; (2004) The DNA sequence and analysis of human chromosome 13. Nature , 428 (6982) pp. 522-528. 10.1038/nature02379.

de Laat, HB; de Groot, PG; Mackie, IJ; Schoormans, S; Adam, M; Purdy, G; Woodhams, B; (2004) The role of annexin A5 in the antiphospholipid syndrome. In: THROMBOSIS RESEARCH. (pp. 654 - 654). PERGAMON-ELSEVIER SCIENCE LTD

E

ELhamidi, A; Hamoudi, RA; Kocjan, G; Du, MQ; (2004) Cervical intraepithelial neoplasia: prognosis by combined LOH analysis of multiple loci. GYNECOL ONCOL , 94 (3) 671 - 679. 10.1016/j.ygyno.2004.06.013.

Eardley, KS; Ferreriera, MAS; Howie, AJ; Gosling, P; Lipkin, GW; (2004) Urinary albumin excretion: a predictor of glomerular findings in microscopic haematuria. QJM , 97 pp. 297-301.

Eckhardt, F; Beck, S; Gut, IG; Berlin, K; (2004) Future potential of the human epigenome project. EXPERT REV MOL DIAGN , 4 (5) 609 - 618.

Eguchi, M; Eguchi-Ishimae, M; Green, AR; Enver, T; Greaves, M; (2004) Directing oncogenic fusion genes into stem cells via an SCL enhancer. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 66A-66A). AMER SOC HEMATOLOGY

Ellis, IO; Bartlett, J; Dowsett, M; Humphreys, S; Jasani, B; Miller, K; Pinder, SE; (2004) Updated recommendations for HER2 testing in the UK. J CLIN PATHOL , 57 (3) 233 - 237. 10.1136/jcp.2003.007724.

Eward, KL; Obermann, EC; Shreeram, S; Loddo, M; Fanshawe, T; Williams, C; Jung, HI; (2004) DNA replication licensing in somatic and germ cells. J CELL SCI , 117 (24) 5875 - 5886. 10.1242/jcs.01503. Green open access
file

F

Feber, A; Clark, J; Goodwin, G; Dodson, AR; Smith, PH; Fletcher, A; Edwards, S; (2004) Amplification and overexpression of E2F3 in human bladder cancer. ONCOGENE , 23 (8) 1627 - 1630. 10.1038/sj.onc.1207274.

Feinberg, J; Fieschi, C; Doffinger, R; Feinberg, M; Leclerc, T; Boisson-Dupuis, S; Picard, C; (2004) Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol , 34 (11) pp. 3276-3284. 10.1002/eji.200425221.

Feingold, EA; Good, PJ; Guyer, MS; Kamholz, S; Liefer, L; Wetterstrand, K; Collins, FS; (2004) The ENCODE (ENCyclopedia of DNA elements) Project. SCIENCE , 306 (5296) 636 - 640. 10.1126/science.1105136.

Ffolkes, LV; Freeman, A; Harland, SJ; Parkinson, MC; (2004) Are there diagnostic problems with testis tumours? JOURNAL OF PATHOLOGY , 204 35A - 35A.

Flanagan, J; Healey, S; Young, J; Whitehall, V; Trott, D; Newbold, R; Chenevix-Trench, G; (2004) Mapping of a candidate colorectal cancer tumour suppressor gene to a 900 kilobase region on the short arm of chromosome 8. Genes, Chromosomes and Cancer , 40 (3) pp. 247-260.

Flores, L; Henry, J; Bailey, S; Tahberhai, Z; Harris, D; Buchmueller, K; Nguyen, B; (2004) JH-37, a hairpin polyamide, inhibits the binding of nuclear factor-Y to inverted CCAAT boxes in the human topoisomerase II alpha promoter. A biochemical and biophysical study. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U26 - U27). AMER CHEMICAL SOC

Folarin, NI; Baker, RJ; Duke, V; Yogashangary, BC; Vadikolia, C; Wickremasinghe, RG; Casanova, AA; (2004) Zap-70 and 19V(H) mutation status in combination with p53 functional analysis identifies the response of poor prognosis B-CLL patients to conventional cytotoxic agents. In: BLOOD. (pp. 527A - 528A). AMER SOC HEMATOLOGY

Forshew, T; Johnson, CA; (2004) SCAMP: a spreadsheet to collate autozygosity mapping projects. J Med Genet , 41 (12) , Article e125. 10.1136/jmg.2004.023663.

Forster, MD; Madhusudan, S; Muthuramalingam, SR; Braybrooke, JP; Wilner, S; Kaur, K; Han, C; (2004) A phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor alpha Inhibitor in Patients with Metastatic Breast Cancer. Clin Cancer Res. , 10 (19) pp. 6528-6534.

Foster, C; Evans, DGR; Eeles, R; Eccles, D; Ashley, S; Brooks, L; Cole, T; (2004) Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genetic Testing , 8 (1) pp. 23-29.

Foster, CS; Falconer, A; Dodson, AR; Norman, AR; Dennis, N; Fletcher, A; Southgate, C; (2004) Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. ONCOGENE , 23 (35) 5871 - 5879. 10.1038/sj.onc.1207800.

Francis, RJ; Mather, SJ; Chester, K; Sharma, SK; Bhatia, J; Pedley, RB; Waibel, R; (2004) Radiolabelling of glycosylated MFE-23 :: CPG2 fusion protein (MFECP1) with Tc-99m for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT). EUR J NUCL MED MOL I , 31 (8) 1090 - 1096. 10.1007/s00259-004-1474-4.

Freeman, A; Geddes, N; Munson, P; Joseph, J; Ramani, P; Sandison, A; Fisher, C; (2004) Anaplastic lymphoma kinase (ALK1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. MODERN PATHOLOGY , 17 (7) pp. 765-771. 10.1038/modpathol.3800078.

Fricke, B; Jarvis, HG; Reid, CDL; Aguilar-Martinez, P; Robert, A; Quittet, P; Chetty, M; (2004) Four new cases of stomatin-deficient hereditary stomatocytosis syndrome: association of the stomatin-deficient cryohydrocytosis variant with neurological dysfunction. BRIT J HAEMATOL , 125 (6) 796 - 803. 10.1111/j.1365-2141.2004.04965.x.

Friedmann, B; Caplin, M; Hartley, JA; Hochhauser, D; (2004) Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839). CLIN CANCER RES , 10 (19) 6476 - 6486.

G

Gaffan, J; Herbertson, R; Davis, P; Dogan, A; Jones, A; (2004) Bilateral peripheral T-cell lymphoma of the fallopian tubes. Gynecologic Oncology , 95 pp. 736-738.

Gandini, D; Allen, AJ; Nash, MJ; Linch, DC; Gale, RE; (2004) No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia. Haematologica , 89 (5) pp. 613-615. Gold open access

Gandini, D; Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2004) No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia. HAEMATOLOGICA , 89 (5) 613 - 615. Gold open access

Garcia, CA; Robinson, J; Madrigal, AJ; Marsh, SGE; (2004) Killer cell immunoglobulin-like receptors (KIR). In: The EBMT handbook: Haemopoitic Stem Cell Transplantation. (pp. 48-55). European School of Haematology: Paris.

Garcia-Ortiz, JE; Cox, ST; Sandoval-Ramirez, L; Little, AM; Marsh, SGE; Madrigal, JA; Arguello, JR; (2004) A novel HLA-A allele: A*0257. TISSUE ANTIGENS , 63 (1) pp. 85-87. 10.1111/j.1399-0039.2004.00154.x.

Gasco, M; Sullivan, A; Smith, P; Farrell, P; Numico, G; Colantonio, I; Merlano, M; (2004) Transcriptional silencing of Fanconi anaemia genes and clinical outcome in head and neck cancer. J Clin Oncol , 22 (14_suppl) 9546-.

Geary, J; Hodgson, SV; Homfray, T; Mackay, J; Izatt, L; Dorkins, H; Thomas, H; (2004) HNPCC - Where does the buck stop? Journal of Medical Genetics , 41 S36-S36.

Gerrard, G; Butters, TD; Mehta, AB; Hoffbrand, AV; Hughes, D; Burgess, M; Ganeshaguru, K; (2004) Glucosylceramide synthetase inhibitors sensitise B-CLL cells to cytotoxic agents without reversing P-gp functional activity. In: BLOOD. (pp. 334A - 334A). AMER SOC HEMATOLOGY

Gerrard, G; Mitchell, W; Goldstone, A; Chopra, R; Buck, G; Richards, S; Foroni, L; (2004) Sequential quantitative minimal residual disease in BCR-ABL positive acute lymphoblastic leukaemia: Differential observations between major and minor fusion gene rearrangements and variation due to source material. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 311A-311A). AMER SOC HEMATOLOGY

Gerrard, G; Payne, E; Baker, RJ; Jones, DT; Potter, M; Prentice, HG; Ethell, M; (2004) Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. Haematologica , 89 (7) pp. 782-790.

Gerrard, G; Payne, E; Baker, RJ; Jones, DT; Potter, M; Prentice, HG; Ethell, M; (2004) Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. HAEMATOLOGICA , 89 (7) pp. 782-790. Gold open access

Giampieri, S; Garcia-Escudero, R; Green, J; Storey, A; (2004) Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation. ONCOGENE , 23 (34) 5864 - 5870. 10.1038/sj.onc.1207711.

Giampieri, S; Storey, A; (2004) Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from humanpapillomaviruses types 5 and 18. BRIT J CANCER , 90 (11) 2203 - 2209. 10.1038/sj.bjc.6601829.

Ginhoux, F; Turbant, S; Gross, DA; Poupiot, J; Marais, T; Lone, Y; Lemonnier, FA; (2004) HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol Ther , 10 (2) pp. 279-289. 10.1016/j.ymthe.2004.05.012.

Ginsberg, L; Beck, M; Ricci, R; Widmer, U; Mehta, A; (2004) Central nervous system manifestations of Fabry disease: experience from FOS, the Fabry Outcome Survey. JOURNAL OF NEUROLOGY , 251 p. 23.

Ginsberg, L; Richfield, L; Goodwin, S; Milligan, A; Valentine, A; Kendall, B; Zuckerman, J; (2004) Brain MRI appearances in Fabry disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 75 (5) 057-.

Gissen, P; Johnson, CA; Morgan, NV; Stapelbroek, JM; Forshew, T; Cooper, WN; McKiernan, PJ; (2004) Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. NAT GENET , 36 (4) 400 - 404. 10.1038/ng1325.

Godfrey, A; Anderson, J; Papanastasiou, A; Takeuchi, Y; Boshoff, C; (2004) Related ArInhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood

Gomez, K; Laffan, MA; (2004) Hunting for the mutation in inherited thrombophilia. Blood Coagulation and Fibrinolysis , 15 (2) pp. 125-127.

Gomez, K; Laffan, MA; Kemball-Cook, G; Pasi, J; Layton, M; Singer, JD; Tuddenham, EG; (2004) Two novel mutations in severe factor VII deficiency. British Journal of Haematology , 126 (1) pp. 105-110.

Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, J-C; Garcia, L; Danos, O; (2004) Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science , 306 (5702) pp. 1796-1799. 10.1126/science.1104297.

Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, J-C; Garcia, L; Danos, O; (2004) [An opening in Duchenne muscular dystrophy: persistent therapeutic rescue of dystrophin by vectorized antisense mediated exon skipping in mdx mice]. Med Sci (Paris) , 20 (12) pp. 1163-1165. 10.1051/medsci/200420121163.

Graff, CP; Chester, K; Begent, R; Wittrup, KD; (2004) Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C. PROTEIN ENG DES SEL , 17 (4) 293 - 304. 10.1093/protein/gzh038.

Grafone, T; Mancini, M; Ottaviani, E; Renzulli, M; Boschelli, F; Ferraretti, L; Santucci, MA; (2004) A novel 4-anilino-3-quinolinecarbonitrile dual sre and AbI kinase inhibitor (SKI-606) has in vitro activity on CML Ph plus Blast cells resistant to imatinib. In: BLOOD. (pp. 549A - 550A). AMER SOC HEMATOLOGY

Grasso, A; Stigliano, R; Morisco, F; Quaglia, A; Dhillon, AP; Davidson, B; Rolles, K; (2004) Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence. Journal of Hepatology , 40 130-.

Grasso, A; Stigliano, R; Morisco, F; Quaglia, A; Dhillon, AP; Davidson, B; Rolles, K; (2004) Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence. Gut , 53 A119-A119.

Grasso, A; Stigliano, R; Morisco, F; Quaglia, A; Dhillon, AP; Davidson, B; Rolles, K; (2004) Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence. In: JOURNAL OF HEPATOLOGY. (pp. 46 - 46). ELSEVIER SCIENCE BV

Gray, JT; Davidoff, AM; Nathwani, AC; (2004) A novel human factor IX expression cassette packaged as self-complementary DNA dimers in adeno-associated virus vectors results in dramatically improved liver transduction, significantly improving prospects for hemophilia B gene therapy. In: BLOOD. (pp. 869A - 869A). AMER SOC HEMATOLOGY

Green, A; Flynn, A; Pedley, RB; Dearling, J; Begent, R; (2004) Nonuniform absorbed dose distribution in the kidney: The influence of organ architecture. Cancer Biotherapy and Radiopharmaceuticals , 19 (3) pp. 371-377. 10.1089/1084978041425052.

Green, A; Flynn, A; Pedley, RB; Dearling, J; Begent, R; (2004) Nonuniform absorbed dose distribution in the kidney: The influence of organ architecture. CANCER BIOTHER RADIO , 19 (3) 371 - 377.

Green, RA; Cannon, SR; Flanagan, AM; (2004) Chondroid lipoma: correlation of imaging findings and histopathology oc an unusual benign lesion. Skeletal Radiology , 33 (11) pp. 670-673.

Gregson, SJ; Howard, PW; Gullick, DR; Hamaguchi, A; Corcoran, KE; Brooks, NA; Hartley, JA; (2004) Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8 ' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers. J MED CHEM , 47 (5) 1161 - 1174. 10.1021/jm0308971.

Grimwade, D; Enver, T; (2004) Acute promyelocytic leukemia: where does it stem from? LEUKEMIA , 18 (3) pp. 375-384. 10.1038/sj.leu.2403234.

Grimwade, D; Gale, R; Hills, R; Kottaridis, P; Swirsky, D; Gilkes, A; Nugent, E; (2004) The relationship between FLT3 mutation status, biological characteristics and outcome in patients with acute promyelocytic leukaemia. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 69 - 69). BLACKWELL PUBLISHING LTD

Guinn, BA; Gilkes, AF; Mufti, GJ; Linch, D; Burnett, AK; Mills, KI; (2004) Use of cDNA microarray analysis to identify cancer testes antigen expression in presentation acute myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 125 51-.

H

Hackshaw, A; (2004) Tobacco Smoke and Involuntary Smoking (A Hackshaw member of expert working group). WHO/IARC, Lyon, France

Hackshaw, AK; (2004) Tobacco and other disorders. In: Boyle, P and Gray, N and Henningfield, J and Seffrin, J and Zatonski, W, (eds.) Tobacco: The Public Health Disaster of the Twentieth Century. (pp. 593-619). Oxford University Press

Hackshaw, AK; Sweetenham, J; Knight, A; (2004) Are hematopietic growth factors worthwhile in the management of previously untreated patients with high-grade non-Hodgkin’s lymphoma? British Journal of Cancer , 90 pp. 1302-1305.

Hague, A; Eveson, JW; MacFarlane, M; Huntley, S; Janghra, N; Thavaraj, S; (2004) Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage. JOURNAL OF PATHOLOGY , 204 (2) pp. 175-182. 10.1002/path.1630.

Hall, C; (2004) Screening for gullet cancer may save lives. Telegraph Media Group, London, UK.

Hall-Craggs, MA; Porter, J; Gatehouse, PD; Bydder, GM; (2004) Ultrashort echo time (UTE) MRI of the spine in thalassaemia. BRIT J RADIOL , 77 (914) 104 - 110. 10.1259/bjr/53300812.

Hallowell, N; Mackay, J; Richards, M; Gore, M; Jacobs, I; (2004) High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: A descriptive study. Genetic Testing , 8 (2) pp. 148-156.

Hamoudi, R; Diss, TC; Oksenhendler, E; Pan, LX; Carbone, A; Ascoli, V; Boshoff, C; (2004) Distinct cellular origins of primary effusion lymphoma with and without EBV infection. LEUKEMIA RES , 28 (4) 333 - 338. 10.1016/j.leukres.2003.08.003.

Hampel, C.; (2004) Deregulation of E2f-1 and chemosensitivity. Doctoral thesis, University of London. Green open access
file

Harbord, M; Marks, DJB; Oukrif, D; Novelli, M; Segal, AW; Bloom, S; (2004) A novel method to investigate the inflammatory response in the bowel, and confirmation of its impairment in Crohn's disease. In: GUT. (pp. A103 - A103). B M J PUBLISHING GROUP

Harney, J; Shah, N; Short, S; Daley, F; Groom, N; Wilson, GD; Joiner, MC; (2004) The evaluation of low dose hyper-radiosensitivity in normal human skin. Radiotherapy and Oncology , 70 (3) pp. 319-329. 10.1016/j.radonc.2004.01.015.

Harney, J; Short, S; Shah, N; Joiner, M; Saunders, MI; (2004) Low dose hyper-radiosensitivity in metastatic tumors. International Journal of Radiation Oncology Biology Physics , 59 (4) pp. 1190-1195. 10.1016/j.ijrobp.2003.12.029.

Hart, DP; Thomson, KJ; Bannerjee, L; Morris, EC; Linch, DC; Goldstone, AH; Peggs, KS; (2004) Very low dose aciclovir prophylaxis postallogeneic stem cell transplantation prevents varicella zoster infection without development of clinically relevant resistance. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 29 - 30). BLACKWELL PUBLISHING LTD

Hartley, J.A.; Spanswick, V.J.; Brooks, N.; Clingen, P.H.; McHugh, P.J.; Hochhauser, D.; Pedley, R.B.; (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Cancer Research , 64 (18) pp. 6693-6699.

Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. Mutagenesis , 19 (6) 15-.

Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. MUTAGENESIS , 19 (6) 504 - 504.

Hartley, JA; Spanswick, VJ; Brooks, N; Clingen, PH; McHugh, PJ; Hochhauser, D; Pedley, RB; (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 1: Cellular pharmacology, in vitro and initial in vivo antitumor activity. CANCER RES , 64 (18) 6693 - 6699.

Hartley, JA; Spanswick, VJ; Brooks, N; Clingen, PH; McHugh, PJ; Hochhauser, D; Pedley, RB; (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity. Cancer Res , 64 (18) pp. 6693-6699. 10.1158/0008-5472.CAN-03-2941.

Haynes, SVZ; Dudderidge, TJ; (2004) Emergency contraception: the journey so far. BJOG-INT J OBSTET GY , 111 (1) 91 - 91. 10.1046/j.1471-5028.2003.00020.x.

Helena Selby, BBCWSABBCR4; (2004) BBC World Service Health Matters Programme on Lung Cancer. UNSPECIFIED

Henderson, SR; Reuss, H; Hardie, RC; (2004) Single photon responses in Drosophila photoreceptors and their regulation by Ca2+. The Journal of physiology , 524 (1) pp. 179-194.

Henry, JA; Le, NM; Nguyen, B; Howard, CM; Bailey, SL; Horick, SM; Buchmueller, KL; (2004) Targeting the inverted CCAAT box 2 in the topoisomerase II alpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: Design, synthesis, molecular biology, and biophysical studies. BIOCHEMISTRY-US , 43 (38) 12249 - 12257. 10.1021/bi048785z.

Herrero, J; Vaquerizas, JM; Al-Shahrour, F; Conde, L; Mateos, A; Diaz-Uriarte, JSR; Dopazo, J; (2004) New challenges in gene expression data analysis and the extended GEPAS. NUCLEIC ACIDS RESEARCH , 32 W485-W491. 10.1093/nar/gkh421.

Hewison, M; Zehnder, D; Chakraverty, R; Adams, JS; (2004) Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. MOLECULAR AND CELLULAR ENDOCRINOLOGY , 215 (1-2) 31 - 38. 10.1016/j.mce.2003.11.017.

Hing, KA; Saeed, S; Annaz, B; Buckland, T; Revell, PA; (2004) Microporosity affects bioactivity of macroporous hydroxyapatite bone graft substitutes. Key Engineering Materials , 254-25 pp. 273-276.

Hollyman, D.R.; (2004) Cellular targets of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. Doctoral thesis, University of London. Green open access
file

Horton, R; Wilming, L; Rand, V; Lovering, RC; Bruford, EA; Khodiyar, VK; Lush, MJ; (2004) Gene map of the extended human MHC. NAT REV GENET , 5 (12) 889 - 899. 10.1038/nrg1489.

Hoskin, PJ; (2004) The RIB trial. Clinical Oncology , 16 (7) pp. 445-446.

Hoskin, PJ; (2004) Should all breast cancer patients with symptomatic bone metastasis be treated with bisphosphonates? The case against. Clinical Oncology , 16 (2) pp. 112-114.

Hoskin, PJ; Decanha, SM; P, G-J; R, ; (2004) High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Radiotherapy and Oncology , 73 pp. 195-198.

Hoskin, PJ; Sibtain, A; Daley, FM; Saunders, MI; Wilson, GD; (2004) The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiotherapy and Oncology , 72 (2) pp. 159-168.

Howie, AJ; (2004) Defining the role of pathology services in the diagnosis and staging of renal cell carcinoma. In: Aitchison, M and Oliver, RTD and Miles, A, (eds.) The Effective Management of Renal Cell Carcinoma. (pp. 49-53). Aesculapius Medical Press: London.

Howie, AJ; Adu, D; (2004) Different meanings of 'glomerular tip lesion'. Kidney International , 66 1716-.

Howie, AJ; Ferreira, MAS; Lipkin, GW; Adu, D; (2004) Measurement of chronic damage in the donor kidney and graft survival. Transplantation , 77 pp. 1058-1065. 10.1097/01.TP.0000120177.44144.FF.

Hughes, DA; Baker, RJ; Richfield, L; Milligan, A; Bruce, R; Mehta, AB; (2004) Balanced oral substrate reduction therapy for patients with mild to moderate Gaucher's disease: Initial results in clinical practice. In: BLOOD. (pp. 41B - 42B). AMER SOC HEMATOLOGY

Hughes, DA; Baker, RJ; Wright, F; Mehta, AB; (2004) The hypergammaglobinaemia of Gauchers disease is not reversed by enzyme replacement therapy. BRITISH JOURNAL OF HAEMATOLOGY , 125 (Suppleme) 59-.

Hughes, DA; Duke, VM; Baker, RJ; Wright, F; Foroni, L; Atul, MB; (2004) High prevalence of B-cell clonality in patients with Gaucher's disease. In: BLOOD. (pp. 657A - 657A). AMER SOC HEMATOLOGY

Hughes, DA; Li, A; Keshav, S; Mehta, A; (2004) Hepcidin dysregulation in patients with type 1 Gaucher's disease. In: BLOOD. (pp. 42B - 43B). AMER SOC HEMATOLOGY

Hughes, DA; Mehta, AB; (2004) Abnormal distribution of cell surface receptors in glycosphingolipid storage disorders: an in vitro model of Gaucher's and Fabry disease. BRITISH JOURNAL OF HAEMATOLOGY , 125 59 - 59.

Hughes, DA; Stuart-Smith, SE; Bain, BJ; (2004) How should stainable iron in bone marrow films be assessed? J Clin Pathol , 57 (10) pp. 1038-1040. 10.1136/jcp.2003.015834.

Hughes, SE; (2004) The pathology of hypertrophic cardiomyopathy. Histopathology , 44 pp. 412-427.

Huhalov, A; Chester, KA; (2004) Engineered single chain antibody fragments for radioimmunotherapy. Q J Nucl Med Mol Imaging , 48 (4) pp. 279-288.

Huhalov, A; Graff, C; Wittrup, KD; Tolner, B; Pedley, RB; Vervecken, W; Contreras, R; (2004) HSAbodies: A new class of engineered antibody-based molecules for targeting cancer. BRITISH JOURNAL OF CANCER , 91 S63 - S63.

Huhalov, A; Spencer, DIR; Chester, KA; (2004) A strategy for characterizing antibody/antigen interactions using proteinchip arrays. In: Conn, PM, (ed.) Handbook of proteomic methods. (pp. 117-128). Humana Press: New Jersey.

Humphray, SJ; Oliver, K; Hunt, AR; Plumb, RW; Loveland, JE; Howe, KL; Andrews, TD; (2004) DNA sequence and analysis of human chromosome 9. NATURE , 429 (6990) 369 - 374. 10.1038/nature02465.

I

Irshad, S; Pedley, RB; Anderson, J; Latchman, DS; Budhram-Mahadeo, V; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J BIOL CHEM , 279 (20) 21617 - 21627. 10.1074/jbc.M312506200. Gold open access

Irshad, S.; Pedley, R.B.; Anderson, J.; Latchman, D.S.; Budhram-Mahadeo, V.; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. Journal of Biological Chemistry , 279 (20) pp. 21617-21627. 10.1074/jbc.M312506200. Gold open access

Irshad, S.; Pedley, R.B.; Anderson, J.; Latchman, D.S.; Budhram-Mahadeo, V.; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. Journal of Biological Chemistry , 279 (20) p. 21617. 10.1074/jbc.M312506200. Gold open access

Isaacson, PG; Du, MQ; (2004) Timeline: MALT lymphoma: from morphology to molecules. Nature Reviews Cancer , 4 pp. 644-653.

Israeli, D; Benchaouir, R; Ziaei, S; Rameau, P; Gruszczynski, C; Peltekian, E; Danos, O; (2004) FGF6 mediated expansion of a resident subset of cells with SP phenotype in the C2C12 myogenic line. J Cell Physiol , 201 (3) pp. 409-419. 10.1002/jcp.20088.

J

Jadeja, S; van Haelst, M; Darling, S; McGregor, L; Adams, R; Scambler, P; (2004) Fraser syndrome and mouse blebbed mutants. GENETICAL RESEARCH , 84 (2) 120 - 120.

Jakupovic, I; Grandage, VL; Linch, DC; Khwaja, A; (2004) Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells. BLOOD , 103 (8) 3230 - 3232.

Jakupovic, I.; Grandage, V.L.; Linch, D.C.; Khwaja, A.; (2004) Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells. Blood , 103 (8) pp. 3230-3232. 10.1182/blood-2003-06-1985. Green open access
file

Janeway, C; Travers, P; Walport, M; Shlomick, M; (2004) Immunobiology: The immune system in health and disease. [Book]. (1 vols). (6th ed.). Garland Science: New York.

Jennings, BH; Shah, S; Yamaguchi, Y; Seki, M; Phillips, RG; Handa, H; Ish-Horowicz, D; (2004) Locus-specific requirements for Spt5 in transcriptional activation and repression in Drosophila. Curr Biol , 14 (18) pp. 1680-1684. 10.1016/j.cub.2004.08.066.

Jennings, I; Mackie, I; Arnout, J; Preston, FE; UK Natl External Quality, ; (2004) Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UKNEQAS proficiency testing programme. J THROMB HAEMOST , 2 (12) 2178 - 2184.

Jia, L; Spanswick, VJ; Reid, JM; Kuffel, M; Buhrow, SA; Ames, MM; Hartley, JA; (2004) Use of the comet assay as a surrogate biomarker for the in vivo measurement of DNA damage to lymphocytes. Proceedings of the American Association for Cancer Research , 45 1969-.

Johnson, KS; Chicken, DW; Pickard, DCO; Lee, AC; Briggs, G; Falzon, M; Bigio, IJ; (2004) Elastic scattering spectroscopy for intraoperative determination of sentinel lymph node status in the breast. J BIOMED OPT , 9 (6) 1122 - 1128. 10.1117/1.1802191.

Jones, C; Mackay, A; Grigoriadis, A; Cossu, A; Reis-Filho, JS; Fulford, L; Dexter, T; (2004) Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer. CANCER RES , 64 (9) 3037 - 3045.

Jones, DT; Addison, E; North, JM; Lowdell, MW; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. BLOOD , 103 (5) 1855 - 1861. 10.1182/blood-2003-05-1603.

Jones, DT; Addison, E; North, JM; Lowdell, MW; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. Blood , 103 (5) pp. 1855-1861. 10.1182/blood-2003-05-1603. Green open access
file

K

Kakkar, AK; Bundred, N; Carpenter, R; Makris, A; Merriman, H; Walker, ID; (2004) Venous thromboembolism in cancer patients. Guidelines. EGUIDELINES , 23 pp. 311-314.

Kalra, D; Singleton, P; Ingram, D; Milan, J; MacKay, J; Detmer, D; Rector, A; (2004) Security and confidentiality approach for the Clinical E-ScienceFramework (CLEF). In: (Proceedings) Health Grid 2004. : Clermont-Ferrand, France.

Keeling, DM; Mackie, IJ; Moody, A; Watson, HG; Haemostasis Thrombosis Task Force, ; Brit Comm Standards Haematology, ; (2004) The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D-dimer assays to reduce the need for diagnostic imaging. BRIT J HAEMATOL , 124 (1) 15 - 25.

Kemp, Z; Thirlwell, C; Sieber, O; Silver, A; Tomlinson, I; (2004) An update on the genetics of colorectal cancer. HUM MOL GENET , 13 R177 - R185. 10.1093/hmg/ddh247.

Khakoo, SI; Thio, CL; Martin, MP; Brooks, CR; Gao, XJ; Astemborski, J; Cheng, J; (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. SCIENCE , 305 (5685) 872 - 874.

Kiakos, K; Hartley, JA; Price, C; Lingerfelt, B; Handl, H; Lee, M; (2004) Design, synthesis and DNA alkylation specificity of novel achiral seco-CI-polyamide hairpin conjugates. Proceedings of the American Association for Cancer Research , 45 3091-.

Kiakos, K; Mchugh, PJ; Hartley, JA; Sato, K; Summerville, K; C, L; M, ; (2004) Design, synthesis and biological evaluation of AS-I-145, a novel achiral amino seco-CBI. Proceedings of the American Association for Cancer Research , 45 3998-.

Kiepiela, P; Leslie, AJ; Honeyborne, I; Ramduth, D; Thobakgale, C; Chetty, S; Rathnavalu, P; (2004) Dominant influence of HLA-B in mediating the potential co- evolution of HIV and HLA. Nature , 432 (7018) pp. 769-774.

Kim, JB; O'Hare, MJ; Stein, R; (2004) Models of breast cancer: is merging human and animal models the future? Breast Cancer Res , 6 (1) pp. 22-30. 10.1186/bcr645.

Kim, JB; Stein, R; O'Hare, MJ; (2004) Three-dimensional in vitro tissue culture models of breast cancer-- a review. Breast Cancer Res Treat , 85 (3) pp. 281-291. 10.1023/B:BREA.0000025418.88785.2b.

Kooistra, K; Zhang, YH; Henriquez, NV; Weiss, B; Mumberg, D; Noteborn, MH; (2004) TT virus-derived apoptosis-inducing protein induces apoptosis preferentially in hepatocellular carcinoma-derived cells. pp. 1445-1450.

Kristeleit, RS; Stimson, L; Workman, P; Aherne, G; (2004) Histone modification enzymes: novel targets for cancer drugs. Expert Opinion on Emerging Drugs , 9 (1)

Kroeger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; (2004) Comparison between anti-thymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with multiple myeloma. In: BLOOD. (pp. 280A - 281A). AMER SOC HEMATOLOGY

Kroger, N; Thomson, K; Zabelina, T; Peggs, K; Chopra, R; Shimoni, A; Nagler, A; (2004) Comparison between anti-thymocyte globulin and alemtuzumab as part of the melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with lymphoid malignancies. In: BONE MARROW TRANSPLANTATION. (pp. S11 - S11). NATURE PUBLISHING GROUP

Kupchinsky, S; Centioni, S; Howard, T; Trzupek, J; Roller, S; Carnahan, V; Townes, H; (2004) A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. BIOORGAN MED CHEM , 12 (23) 6221 - 6236.

Kupchinsky, S; Centioni, S; Howard, T; Trzupek, J; Roller, S; Carnahan, V; Townes, H; (2004) A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. Bioorganic and Medicinal Chemistry , 12 (23) pp. 6221-6236.

Kyriakou, CA; Goldstone, AH; Sureda, A; Yong, K; D'Sa, S; Taghipour, G; de Elvira, CR; (2004) Patients with lymphoplasmacytic lymphoma can be salvaged with autologous stem cell transplantation, irrespectively of the number of previous treatment lines. Analysis of 146 cases from the European Bone Marrow Transplant Registry (EBMT). In: BLOOD. (pp. 7A - 7A). AMER SOC HEMATOLOGY

Kyriakou, CA; Goldstone, AH; Sureda, A; Yong, K; Taghipour, G; de Elvira, CR; Linch, DC; (2004) Role of allogeneic stem cell transplantation in lymphoplasmacytic lymphoma. Analysis of 61 cases from the European Bone Marrow Registry (EBMT). In: BLOOD. (pp. 909A - 909A). AMER SOC HEMATOLOGY

L

Lacy, ER; Nguyen, B; Le, M; Cox, KK; O'Hare, C; Hartley, JA; Lee, M; (2004) Energetic basis for selective recognition of T center dot G mismatched base pairs in DNA by imidazole-rich polyamides. NUCLEIC ACIDS RES , 32 (6) 2000 - 2007. 10.1093/nar/gkh515. Gold open access

Ladesmaki, A; Kimby, E; Duke, V; Foroni, L; Hammarstroem, L; (2004) ATM mutations in B-cell chronic lymphocytic leukemia. HAEMATOLOGICA , 89 (1) pp. 109-110. Gold open access

Lajmi, AR; Sleep, S; Ng, C; Zhou, JF; Spence, YY; Davidoff, AM; Nathwani, AC; (2004) Scaleable membrane chromatography purification method for adeno-associated viral vectors. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U237 - U237). AMER CHEMICAL SOC

Landreau, CAS; LePla, RC; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) Delineating noncovalent interactions between the azinomycins and double-stranded DNA: Importance of the naphthalene substitution pattern on interstrand cross-linking efficiency. ORG LETT , 6 (20) 3505 - 3507. 10.1021/ol048653y.

Lankester, KJ; Maxwell, RJ; Pedley, RB; Hill, SA; Rustin, GJS; Tozer, GM; (2004) Acute anti-vascular effects of combretastatin A4 phosphate (CA-4-P) on the SW1222 tumour as measured by dynamic contrast enhanced (DCE)-MRI. BRITISH JOURNAL OF CANCER , 91 S16 - S16.

Laurence, A; Marin, D; Clark, R; Shepherd, P; Mackinnon, S; (2004) Frequency of blast crisis after achieving complete cytogenetic remission in first chronic phase CML patients who recieved imatinib therapy within six months of diagnosis. In: BLOOD. (pp. 292A - 292A). AMER SOC HEMATOLOGY

Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. Mutagenesis , 19 (6) 51-.

Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. MUTAGENESIS , 19 (6) 516 - 516.

Ledermann, JA; Wheeler, S; (2004) How should we manage patients with "platinum-sensitive" recurrent ovarian cancer? CANCER INVEST , 22 2 - 10. 10.1081/CNV-200030117.

Leonard, RCF; Lind, M; Twelves, C; Coleman, R; van Belle, S; Wilson, C; Ledermann, J; (2004) Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: A randomized trial. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , 96 (14) pp. 1076-1083.

Leonard, RCF; Lind, M; Twelves, C; Coleman, R; van Belle, S; Wilson, C; Ledermann, J; (2004) Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial. J Natl Cancer Inst , 96 (14) pp. 1076-1083. 10.1093/jnci/djh188.

Litchfield, TM; Gilchrist, S; Sunderland, R; Folkard, M; Short, S; Prise, K; (2004) A three dimensional tissue culture model for microbeam studies. In: (pp. P 462.4-).

Liu, HX; Hamoudi, RA; Ye, HT; Ruskone-Fourmestraux, A; Dogan, A; Isaacson, PG; Du, MQ; (2004) t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks. BRITISH JOURNAL OF HAEMATOLOGY , 125 (3) pp. 318-329. 10.1111/j.1365-2141.2004.04909.x.

Liu, WM; Strauss, SJ; Chaplin, T; Shahin, S; Propper, DJ; Young, BD; Joel, SP; (2004) s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line. Hematol J , 5 (3) 247-54-247-54.

Lowe, GDO; Rumley, A; Mackie, IJ; (2004) Plasma fibrinogen. ANN CLIN BIOCHEM , 41 430 - 440.

M

MacGregor, A; Hackshaw, A; (2004) Prevalence of migraine on each day of the natural menstrual cycle. Neurology , 63 pp. 351-353.

Maccioni, RB; Lavados, M; Maccioni, CB; Mendoza-Naranjo, A; (2004) Biological markers of Alzheimer's disease and mild cognitive impairment. Curr Alzheimer Res , 1 (4) pp. 307-314.

Mackie, I; Yarranton, H; Machin, S; Pinkoski, L; Corash, L; (2004) Von Willebrand factor cleaving protease is retained in intercept plasma. In: TRANSFUSION. (pp. 102A - 102A). BLACKWELL PUBLISHING INC

Mackie, IJ; Lawrie, AS; Greenfield, RS; Guinto, ER; Machin, SJ; (2004) A new lupus anticoagulant test based on dilute prothrombin time. In: THROMBOSIS RESEARCH. (pp. 673 - 674). PERGAMON-ELSEVIER SCIENCE LTD

Mackie, IJ; de Laat, HB; Purdy, G; Adam, M; Woodhams, B; Derksen, RHWM; de Groot, PG; (2004) A prototype commercial ELISA for protein S antibodies. In: THROMBOSIS RESEARCH. (pp. 639 - 639). PERGAMON-ELSEVIER SCIENCE LTD

Mackinnon, S; Thomson, K; Morris, E; Kottaridis, PD; Peggs, KS; (2004) Reduced intensity transplantation: where are we now? HEMATOLOGY JOURNAL , 5 S34 - S38. 10.1038/sj.thj.6200419.

Madrigal, A; Rusakiewicz, S; Dodi, A; I, R; Robert, ; (2004) Immunotherapy with alloreactive T-cells? THE HEMATOLOGY JOURNAL , 5 (Suppl 3) S91-S95.

Makris, A; (2004) Critical commentary of: HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. Women's Oncology Review , 4 pp. 277-278.

Makris, A; (2004) Critical commentary of: Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. Women's Oncology Review , 4 pp. 213-214.

Makris, A; Glynne-Jones, R; Sebag-Montefiore, D; Samuel, L; Myint, S; Levine, E; Martin, A; (2004) Compliance to chemotherapy with oxaliplatin and 5fluorouracil in patients with advanced rectal cancer who rave received prior high-dose pelvic radiotherapy. British Journal of Cancer , 91 S34-S34.

Marafioti, T; Mancini, C; Ascani, S; Sabattini, E; Zinzani, PL; Pozzobon, M; Pulford, K; (2004) Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. Haematologica , 89 (8) pp. 957-964.

Marafioti, T; Pozzobon, M; Hansmann, M-L; Delsol, G; Pileri, SA; Mason, DY; (2004) Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood , 103 (1) pp. 188-193. 10.1182/blood-2003-05-1487.

Maria, V; (2004) Severe cholestatic hepatitis induced by pyritinol. BMJ , 328 (7439) pp. 572-574. 10.1136/bmj.328.7439.572.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update April 2004. Hum Immunol , 65 (7) pp. 770-771.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update August 2004. Tissue Antigens , 64 (6) pp. 711-712. 10.1111/j.1399-0039.2004.00334.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update August 2004. Eur J Immunogenet , 31 (6) 279-. 10.1111/j.1365-2370.2004.00485.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update February 2004. Eur J Immunogenet , 31 (2) 101-. 10.1111/j.1365-2370.2004.00453.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update February 2004. Tissue Antigens , 64 (1) pp. 106-107. 10.1111/j.1399-0039.2004.00265.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update February 2004. Hum Immunol , 65 (7) 768-.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update January 2004. Eur J Immunogenet , 31 (2) 99-. 10.1111/j.1365-2370.2004.00451.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update January 2004. Tissue Antigens , 63 (6) pp. 619-620. 10.1111/j.0001-2815.2004.00254.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update January 2004. Hum Immunol , 65 (7) 767-. 10.1016/j.humimm.2004.05.005.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update July 2004. Hum Immunol , 65 (11) pp. 1411-1412. 10.1016/j.humimm.2004.09.013.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update June 2004. Hum Immunol , 65 (11) pp. 1409-1410. 10.1016/j.humimm.2004.09.012.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update March 2004. Eur J Immunogenet , 31 (2) 103-. 10.1111/j.1365-2370.2004.00454.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update March 2004. Tissue Antigens , 64 (1) pp. 108-109. 10.1111/j.1399-0039.2004.00266.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update March 2004. Hum Immunol , 65 (7) 769-.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update May 2004. Hum Immunol , 65 (12) pp. 1546-1547.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2003. Hum Immunol , 65 (1) pp. 90-91.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2003. Tissue Antigens , 63 (2) pp. 190-191.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2004. Tissue Antigens , 64 (6) pp. 713-714. 10.1111/j.1399-0039.2004.00335.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2004. Eur J Immunogenet , 31 (6) 281-. 10.1111/j.1365-2370.2004.00486.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update April 2004. Eur J Immunogenet , 31 (4) pp. 195-196. 10.1111/j.1365-2370.2004.00468.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update August 2003. Tissue Antigens , 63 (1) pp. 98-99.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update December 2003. Tissue Antigens , 63 (5) pp. 505-506. 10.1111/j.1399-0039.2004.00213.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update July 2003. Tissue Antigens , 63 (1) pp. 96-97.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update June 2004. Eur J Immunogenet , 31 (4) pp. 199-200. 10.1111/j.1365-2370.2004.00472.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update May 2004. Eur J Immunogenet , 31 (4) pp. 197-198. 10.1111/j.1365-2370.2004.00469.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update November 2003. Tissue Antigens , 63 (5) pp. 503-504. 10.1111/j.0001-2815.2004.00212.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update October 2003. Tissue Antigens , 63 (5) pp. 501-502. 10.1111/j.0001-2815.2004.00211.x.

Martin, HM; Moore, KP; Bosmans, E; Davies, S; Burroughs, AK; Dhillon, AP; Tosh, D; (2004) Xanthine oxidoreductase is present in bile ducts of normal and cirrhotic liver. FREE RADICAL BIO MED , 37 (8) 1214 - 1223. 10.1016/j.freeradbiomed.2004.06.045.

Martineau, Y; Le Bec, C; Monbrun, L; Allo, V; Chiu, I-M; Danos, O; Moine, H; (2004) Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol Cell Biol , 24 (17) pp. 7622-7635. 10.1128/MCB.24.17.7622-7635.2004.

Martinelli, G; Martelli, AM; Grafone, T; Rosti, G; Mantovani, I; Cappellini, A; Tazzari, PL; (2004) A new abl kinase inhibitor (AMN107) has in vitro activity on CML Ph plus Blast cells resistant to imatinib. In: BLOOD. (pp. 255B - 255B). AMER SOC HEMATOLOGY

Martins, LM; Morrison, A; Klupsch, K; Fedele, V; Moisoi, N; Teismann, P; Abuin, A; (2004) Neuroprotective role of the reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. MOL CELL BIOL , 24 (22) 9848 - 9862. 10.1128/MCB.24.22.9848-9862.2004.

Masir, N; Jones, M; Pozzobon, M; Marafioti, T; Volkova, OY; Mechetina, LV; Hansmann, M-L; (2004) Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. Br J Haematol , 127 (3) pp. 335-343. 10.1111/j.1365-2141.2004.05193.x.

Mathias, MC; Mackie, I; Khair, K; Machin, SJ; Liesner, R; (2004) Defective fibrinolysis in children with severe haemophilia A. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING LTD

Mayer, A; Francis, R; Sharma, SK; Sully, C; Parker, S; Tolner, B; Griffin, N; (2004) A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P. British Journal of Cancer , 91 S8-S8.

Mayer, A; Francis, R; Sharma, SK; Sully, C; Parker, S; Tolner, B; Griffin, N; (2004) A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P. In: BRITISH JOURNAL OF CANCER. (pp. S8 - S8). NATURE PUBLISHING GROUP

Mayer, A; Sharma, SK; Tolner, B; Minton, NP; Purdy, D; Amlot, P; Tharakan, G; (2004) Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT). BRIT J CANCER , 90 (12) 2402 - 2410. 10.1038/sj.bjc.6601888.

Mayer, A; Sharma, SK; Tolner, B; Minton, NP; Purdy, D; Amlot, P; Tharakan, G; (2004) Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT). Br J Cancer , 90 (12) pp. 2402-2410. 10.1038/sj.bjc.6601888.

Mayor, NP; Cox, ST; McWhinnie, AJ; Arguello, JR; Shaw, BE; Little, A-M; Madrigal, JA; (2004) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). TISSUE ANTIGENS , 65 pp. 107-109.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Purdy, G; Lawrie, AS; Watt, H; (2004) Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. BRIT J HAEMATOL , 125 (6) 777 - 787. 10.1111/j.1365-2141.2004.04983.x.

McCabe, DJH; Harrison, P; Sidhu, PS; Mackie, IJ; Purdy, G; Lawrie, AS; Watt, H; (2004) Leucocyte-platelet complex formation is increased in patients with acute symptomatic compared with asymptomatic severe carotid stenosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 522 - 522). B M J PUBLISHING GROUP

McCann, S; Byrne, JL; Rovira, M; Shaw, P; Ribaud, P; Sica, S; Volin, L; (2004) Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. BONE MARROW TRANSPLANTATION , 33 (5) pp. 519-529.

McGonigle, GJ; Glasow, A; Grier, DG; Enver, T; Zelent, A; Lappin, TRJ; Thompson, A; (2004) Regulation of Hox genes by IL-3 in 32D and FDCP-mix cells. In: (Proceedings) Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 38). BLACKWELL PUBLISHING LTD

McGurk, CJ; Cummings, M; Hartley, JA; Masters, JR; (2004) Translational regulation of ERCC1 in human cancer cell lines. Proceedings of the American Association for Cancer Research , 45 2631-.

McMeish, I; Kanfer, EJ; Haynes, R; Giles, C; Harland, SJ; Driver, D; Rustin, GJS; (2004) Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours. British Journal of Cancer , 90 (6) pp. 1169-1175.

McStay, MK; Khan, K; Savage, K; Stubbs, M; Dhillon, AP; Caplin, M; (2004) Neuroendocrine-like differentiation in hepatocellular and pancreatic cancers. In: GASTROENTEROLOGY. (pp. A494 - A494). W B SAUNDERS CO

McTiernan, A; Whelan, JS; (2004) A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma. Sarcoma , 8 (2-3) pp. 71-76. 10.1080/13577140410001711764. Gold open access

Mchugh, PJ; Hartley, JA; (2004) Repair of DNA interstrand crosslinks Produced by Cancer Chemotherapeutic Drugs. In: Panasci, LC and Alaoui-Jamali, MA, (eds.) DNA Repair in Cancer Therapy. (pp. 31-49). Humana Press: Totowa. NJ.

Medzihradszky, KF; Spencer, DIR; Sharma, SK; Bhatia, J; Pedley, RB; Read, DA; Begent, RHJ; (2004) Glycoforms obtained by expression in Pichia pastoris improve cancer targeting potential of a recombinant antibody-enzyme fusion protein. GLYCOBIOLOGY , 14 (1) 27 - 37. 10.1093/glycob/cwh001.

Mehta, A; Beck, M; Ricci, R; Widmer, U; (2004) Fabry disease defined: authors' reply. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (6) p. 450.

Mehta, A; Beck, M; Ricci, R; Widmer, U; Sunder-Plassmann, G; (2004) Fabry outcome survey: need for documentation of dermatological, ophthalmologic and psychiatric affections: authors' reply. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (7) p. 517.

Mehta, A; Ricci, R; Widmer, U; Dehout, F; Garcia, D; Kampmann, C; Linhart, A; (2004) Fabry disease defined: Baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (3) pp. 236-242.

Meja, KK; Catley, MC; Cambridge, LM; Barnes, PJ; Lum, H; Newton, R; Giembycz, MA; (2004) Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J Pharmacol Exp Ther , 309 (2) pp. 833-844. 10.1124/jpet.103.060020.

Miller, RF; Isaacson, PG; Hall-Craggs, M; Lucas, S; Gray, F; Scaravilli, F; An, SF; (2004) Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. ACTA NEUROPATHOL , 108 (1) 17 - 23. 10.1007/s00401-004-0852-0.

Moroncini, G; Kanu, N; Solforosi, L; Abalos, G; Telling, GC; Head, M; Ironside, J; (2004) Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. P NATL ACAD SCI USA , 101 (28) 10404 - 10409. 10.1073/pnas.0403522101.

Morris, E; Thomson, K; Craddock, C; Mahendra, P; Milligan, D; Cook, G; Smith, GM; (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. BLOOD , 104 (13) 3865 - 3871. 10.1182/blood-2004-03-1105.

Morris, E; Thomson, K; Craddock, C; Mahendra, P; Milligan, D; Cook, G; Smith, GM; (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood , 104 (13) pp. 3865-3871. 10.1182/blood-2004-03-1105.

Morris, E; Thomson, K; Craddock, C; Milligan, D; Smith, G; Parker, A; Schey, S; (2004) Long-term follow-up of an alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant (RIT) regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 29 - 29). BLACKWELL PUBLISHING LTD

Morris, E.; Thomson, K.; Craddock, C.; Mahendra, P.; Milligan, D.; Cook, G.; Smith, G.M.; (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood , 104 (13) pp. 3865-3871. 10.1182/blood-2004-03-1105. Green open access
file

Morsi, H; Yong, KL; Jewell, AP; (2004) Evaluation of the Taguchi methods for the simultaneous assessment of the effects of multiple variables in the tumour microenvironment. International Seminars in Surgical Oncology , 1 10.1186/1477-7800-1-7.

Munker, R; Schmid, C; Madrigal, JA; Kolb, HJ; (2004) An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the sixth International Symposium held in Schloss Ellmau, Germany, January 22-24, 2004. BONE MARROW TRANSPLANTATION , 34 (9) pp. 767-780.

Murch, SH; Anthony, A; Casson, DH; Malik, M; Berelowitz, M; Dhillon, AP; Thomson, MA; (2004) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children (Retraction of vol 351, pg 637, 1998). LANCET , 363 (9411) 750 - 750.

Murch, SH; Anthony, A; Casson, DH; Malik, M; Berelowitz, M; Dhillon, AP; Thomson, MA; (2004) Retraction of an interpretation. Lancet , 363 (9411) 750-. 10.1016/S0140-6736(04)15715-2.

Murphy, RT; Mogensen, J; Shaw, A; Kubo, T; Hughes, S; McKenna, WJ; (2004) Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. LANCET , 363 (9406) pp. 371-372. 10.1016/S0140-6736(04)15468-8.

N

Nacheva, E; Brazma, D; Grace, C; (2004) The genetic profile of CML-new revelations with matrix CGH. In: (pp. 805A-806A).

Narat, S; Folarin, NI; Baker, RJ; Duke, V; Yogashangary, BC; Jones, DT; Hart, SM; (2004) The role of multidrug resistance proteins and drug sensitivity in relation to poor prognosis identified by ZAP-70 expression and IgV(H) mutation status in B-CLL. In: BLOOD. (pp. 281B - 281B). AMER SOC HEMATOLOGY

Narat, S; Gandla, J; Mehta, A; (2004) Anti-CD20 monoclonal antibody in the treatment of refractory auto-immune cytopenias in adults. In: (pp. 742a-742a).

Nash, M; Camilleri, R; Everington, T; Cohen, H; (2004) An analysis of the antiphospholipid antibody status of 111 women with late pregnancy morbidity. In: (Proceedings) British society for haematology annual scientific meeting.

Nash, M; Camilleri, R; Mackie, IJ; Machin, SJ; Cohen, H; (2004) An analysis of the beta2GP1/Cys306Gly polymorphism in patients with thrombotic and obstetric disorders. In: (Proceedings) British society for haematology annual scientific meeting.

Nash, MJ; Camilleri, RS; Everington, T; Cohen, H; (2004) An analysis of the antiphospholipid antibody status of 111 women with late pregnancy morbidity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 49). BLACKWELL PUBLISHING LTD

Nash, MJ; Camilleri, RS; Kunka, S; Mackie, IJ; Machin, SJ; Cohen, H; (2004) The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 2 (7) 1077 - 1081.

Nash, MJ; Camilleri, RS; Mackie, IJ; Machin, SJ; Cohen, H; (2004) An analysis of the beta(2)-glycoprotein I Cys306Gly polymorphism in patients with thrombotic and obstetric disorders. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 48). BLACKWELL PUBLISHING LTD

Nash, MJ; Cohen, H; (2004) Management of Jehovah's Witness patients with haematological problems. BLOOD REV , 18 (3) 211 - 217. 10.1016/S0268-960X(03)00065-1.

Nash, MJ; Mackie, IJ; Cohen, H; Machin, SJ; (2004) Antiphospholipid antibodies can reduce the in vitro cleavage of domain V of beta2-glycoprotein I by plasmin. In: THROMBOSIS RESEARCH. (pp. 616 - 616). PERGAMON-ELSEVIER SCIENCE LTD

Nash, MJ; Mackie, IJ; Machin, SJ; (2004) Kallikrein is able to specifically cleave beta2-glycoprotein I in domain V. In: THROMBOSIS RESEARCH. (pp. 620 - 620). PERGAMON-ELSEVIER SCIENCE LTD

Nathwani, AC; Benjamin, R; Nienhuis, AW; Davidoff, AM; (2004) Current status and prospects for gene therapy. VOX SANG , 87 (2) 73 - 81.

Nathwani, AC; Davidoff, AM; Tuddenham, EGD; (2004) Prospects for gene therapy of haemophilia. HAEMOPHILIA , 10 (4) 309 - 318. 10.1111/j.1365-2516.2004.00926.x.

Newsom-Davis, T; Bower, M; Wildfire, A; Thirlwell, C; Nelson, M; Gazzard, B; Stebbing, J; (2004) Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels. LEUKEMIA LYMPHOMA , 45 (9) 1939 - 1941. 10.1080/10428190410001693533.

Nicholls, BM; Bredius, R; Nesbitt, SA; Horton, MA; Flanagan, AM; (2004) Limited evidence of rescue of osteoclast-poor osteopetrosis following successful engraftment by cord blood from an unrelated donor. In: (Proceedings) Annual Meeting of the Bone-and-Tooth-Society. (pp. p. 1034). WILEY-BLACKWELL

Nicholls, BM; Bredius, RG; Nesbitt, SA; Horton, MA; Flanagan, AM; (2004) LITTLE EVIDENCE OF RESCUE OF OSTEOCLAST-POOR OSTEOPETROSIS FOLLOWING 'SUCCESSFUL ENGRAFTMENT' BY CORD BLOOD FROM AN UNRELATED DONOR. CALCIFIED TISSUE INTERNATIONAL , 74 S64-S64.

Nivsarkar, MS; Nathwani, A; Mosley, K; Davies, N; Gregory, LG; David, AL; Themis, M; (2004) Testosterone induced increase in transgene expression in vivo using Adenoviral Gene Delivery Vectors. Presented at: 1st Annual Conference of the British-Society-for-Gene-Therapy, Keble Coll, Oxford, ENGLAND.

Nnene, IO; Nieto, JJ; Crow, JC; Sundaresan, M; MacLean, AB; Perrett, CW; Hardiman, P; (2004) Cell cycle and apoptotic proteins in relation to ovarian epithelial morphology. GYNECOL ONCOL , 92 (1) 247 - 251. 10.1016/j.ygyno.2003.08.040.

Novak-Hofer, I; Waibel, R; Zimmermann, K; Schibli, R; Grünberg, ; J, ; Chester, ; (2004) Radiometal labeling of antibodies and antibody fragments for imaging and therapy. In: Methods Mol Biol. (pp. 481-494). Humana Press

O

O'Connell, NM; McIntosh, JH; Riddell, A; Pascoe, G; Griffioen, A; Lee, CA; Perry, DJ; (2004) Thrombin generation and correlation with bleeding tendency in inherited FXI deficiency. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 44 - 44). BLACKWELL PUBLISHING LTD

O'Donnell, A; Judson, I; Dowsett, M; Raynaud, F; Dearnaley, D; Mason, M; Harland, S; (2004) Hormonal impact of the 17 alpha-hydroxylase/C-17,C-20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer. British Journal of Cancer , 90 (12) pp. 2317-2325.

Obermann, EC; Diss, TC; Hamoudi, RA; Munson, P; Wilkins, BS; Camozzi, MLP; Isaacson, PG; (2004) Loss of heterozygosity at chromosome 9p2 I is a frequent finding in enteropathy-type T-cell lymphoma. JOURNAL OF PATHOLOGY , 202 (2) pp. 252-262. 10.1002/path.1506.

Okkenhaug, K; Bilancio, A; Emery, JL; Vanhaesebroeck, B; (2004) Phosphoinositide 3-kinase in T cell activation and survival. BIOCHEMICAL SOCIETY TRANSACTIONS , 32 pp. 332-335. 10.1042/BST0320332.

Okkenhaug, K; Bilancio, A; Emery, JL; Vanhaesebroeck, B; (2004) Phosphoinositide 3-kinase in T cell activation and survival. Circulation Research , 95 (4) pp. 380-388.

Okorokov, AL; Orlova, EV; Kingsbury, SR; Bagneris, C; Gohlke, U; Williams, GH; Stoeber, K; (2004) Molecular structure of human geminin. NAT STRUCT MOL BIOL , 11 (10) 1021 - 1022. 10.1038/nsmb835.

Orteu, CH; Jansen, T; Beck, M; Mehta, A; Ricci, R; Widmer, U; (2004) The Fabry Outcome Survey is a useful tool to document the natural history of Fabry disease. British Journal of Dermatology , 151 p. 9.

P

Papazisis, KT; Habeshaw, T; Miles, DW; Herceptin-EAP Study Group, ; (2004) Safety and efficacy of the combination of trastuzumab with docetaxel for HER2-positive women with advanced breast cancer. A review of the existing clinical trials and results of the expanded access programme in the UK. Int J Clin Pract , 58 (6) pp. 581-586.

Parini, R; Ramaswami, U; Whybra, C; Mehta, A; Ricci, R; Widmer, U; Beck, M; (2004) Diagnosis of Anderson-Farry disease in childhood. What should we focus on? Pediatric Research , 56 (3) 207-.

Parker, LL; Lacy, SM; Farrugia, LJ; Evans, C; Robins, DJ; O'Hare, CC; Hartley, JA; (2004) A novel design strategy for stable metal complexes of nitrogen mustards as bioreductive prodrugs. J MED CHEM , 47 (23) 5683 - 5689. 10.1021/jm0449866w.

Parsonnet, J; Isaacson, PG; (2004) Bacterial infection and MALT lymphoma. The New England Journal of Medicine , 350 pp. 213-215. 10.1056/NEJMp038200. Green open access
file

Paston, SJ; Dodi, IA; Madrigal, JA; (2004) Progress made towards the development of a CMV peptide vaccine. HUM IMMUNOL , 65 (5) pp. 544-549.

Paston, SJ; Dodi, IA; Madrigal, JA; (2004) Progress made towards the development of a CMV peptide vaccine. HUMAN IMMUNOLOGY , 65 (5) pp. 544-549.

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed enzyme-prodrug therapy. In: UNSPECIFIED (pp. 491-514).

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed enzyme-prodrug therapy. In: UNSPECIFIED (pp. 491-514).

Peggs, K; (2004) Imatinib mesylate - gold standards and silver linings. CLIN EXP MED , 4 (1) 1 - 9. 10.1007/s10238-004-0032-5.

Peggs, K; Mackinnon, S; (2004) Graft-versus-myeloma: are durable responses a clinical reality following donor lymphocyte infusion? LEUKEMIA , 18 (9) 1541 - 1542. 10.1038/sj.leu.2403432.

Peggs, K; Mackinnon, S; Ayuk, FA; Zander, AR; Kröger, N; (2004) Graft-versus-myeloma: Are durable responses a clinical reality following donor lymphocyte infusion? (multiple letters) (2). Leukemia , 18 (9) pp. 1541-1543.

Peggs, KS; (2004) Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy. Expert Rev Anti Infect Ther , 2 (4) pp. 559-573.

Peggs, KS; (2004) Immune reconstitution following stem cell transplantation. LEUKEMIA LYMPHOMA , 45 (6) 1093 - 1101. 10.1080/10428190310001641260.

Peggs, KS; (2004) Role of MabCampath in allogeneic transplantation. Ann Hematol , 83 Sup S66-S68. 10.1007/s00277-004-0850-2.

Peggs, KS; Mackinnon, S; (2004) Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-Cell therapy. HUM IMMUNOL , 65 (5) 550 - 557. 10.1016/j.humimm.2004.02.016.

Peggs, KS; Mackinnon, S; (2004) Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantation. INT J BIOCHEM CELL B , 36 (4) 695 - 701. 10.1016/j.biocel.2003.08.008.

Peggs, KS; Mackinnon, S; (2004) Immune reconstitution following haematopoietic stem cell transplantation. BRIT J HAEMATOL , 124 (4) 407 - 420. 10.1046/j.1365-2141.2003.04767.x.

Peggs, KS; Sureda, A; Hunter, A; Caballero, MD; Cavet, J; Urbano-Ispizua, A; Parker, A; (2004) Impact of in vivo T-cell depletion on outcome following reduced intensity transplantation for Hodgkin lymphoma: Comparison between 2 prospective studies. In: BLOOD. (pp. 230A - 230A). AMER SOC HEMATOLOGY

Peggs, KS; Thomson, K; Hart, DP; Geary, J; Morris, EC; Yong, K; Goldstone, AH; (2004) Dose-escalated donor lymphocyte inftisions following reduced intensity transplantation: toxicity, chimerism, and disease responses. BLOOD , 103 (4) 1548 - 1556.

Peggs, KS; Thomson, K; Hunter, A; Chopra, R; Mahendra, P; Milligan, D; Parker, A; (2004) Exploiting alloreactivity in relapsed and refractory Hodgkin Lymphoma: long-term follow-up of a T-cell-depleted reduced intensity transplant protocol. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 3 - 4). BLACKWELL PUBLISHING LTD

Peggs, KS; Verfuerth, S; Chow, C; Thomson, K; Goldstone, AH; Linch, DC; Mackinnon, S; (2004) Adoptive cellular therapy for cytomegalovirus following allogeneic stem cell transplantation: Toxicity and efficacy. In: BLOOD. (pp. 59A - 59A). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; Pizzy, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S; (2004) Adoptive cellular therapy for early cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T-cell lines. BLOOD CELLS MOLECULES AND DISEASES , 33 (3) 198 - 199.

Peltenburg, LTC; de Bruin, EC; Meersma, D;